Back
Celldex Therapeutics Stock Price Chart
Free presentation on how to trade options for overnight gains
Get the free overnight options training here.
Buy
65
CLDX
Celldex Therapeutics
Last Price:
44.53
Seasonality Move:
-7.29%
7 Day Trial
ALL ACCESS PASS
$
7
$1,300 into $45,000 in just 4 MONTHS?!
See here to see the full details.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLDX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Celldex Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.94 | Buy |
| 20-day SMA: | 38.08 | Buy |
| 50-day SMA: | 36.77 | Buy |
| 200-day SMA: | 36.43 | Buy |
| 8-day EMA: | 39.47 | Buy |
| 20-day EMA: | 38.26 | Buy |
| 50-day EMA: | 37.71 | Buy |
| 200-day EMA: | 37.05 | Buy |
Celldex Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.95 | Buy |
| Relative Strength Index (14 RSI): | 68.94 | Buy |
| Chaikin Money Flow: | 973746 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.74 - 39.54) | Buy |
| Bollinger Bands (100): | (35.43 - 42.63) | Buy |
Celldex Therapeutics Technical Analysis
| Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Celldex Therapeutics Stock
Is Celldex Therapeutics Stock a Buy?
- Celldex Therapeutics share price is 43.86 while CLDX 8-day simple moving average is 38.94, which is a Buy signal.
- The stock price of CLDX is 43.86 while Celldex Therapeutics 20-day SMA is 38.08, which makes it a Buy.
- Celldex Therapeutics 50-day simple moving average is 36.77 while CLDX share price is 43.86, making it a Buy technically.
- CLDX stock price is 43.86 and Celldex Therapeutics 200-day simple moving average is 36.43, creating a Buy signal.
CLDX Technical Analysis vs Fundamental Analysis
Buy
65
Celldex Therapeutics (CLDX)
is a Buy
Is Celldex Therapeutics a Buy or a Sell?
-
Celldex Therapeutics stock is rated a Buy
The current Celldex Therapeutics [CLDX] share price is $43.86. The Score for CLDX is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
Celldex Therapeutics Stock Info
Market Cap:
2.89B
Price in USD:
43.86
Share Volume:
1M
Celldex Therapeutics 52-Week Range
52-Week High:
53.18
52-Week Low:
22.11
Buy
65
Celldex Therapeutics (CLDX)
is a Buy
Celldex Therapeutics Share Price Forecast
-
What is the Celldex Therapeutics stock price today?
The Celldex Therapeutics stock price is 43.86 USD today. -
Will CLDX stock go up or go down?
Celldex Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Celldex Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Celldex Therapeutics is not overvalued.
Is Celldex Therapeutics Stock a Buy?
- Celldex Therapeutics share price is 43.86 while CLDX 8-day exponential moving average is 39.47, which is a Buy signal.
- The stock price of CLDX is 43.86 while Celldex Therapeutics 20-day EMA is 38.26, which makes it a Buy.
- Celldex Therapeutics 50-day exponential moving average is 37.71 while CLDX share price is 43.86, making it a Buy technically.
- CLDX stock price is 43.86 and Celldex Therapeutics 200-day simple moving average is 37.05, creating a Buy signal.
Fundamental Analysis of Celldex Therapeutics
Is Celldex Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.24 per share, an increase this year of $0.28 per share, and a decrease next year of $0.62 per share.
Technical Analysis of Celldex Therapeutics
Should I short Celldex Therapeutics stock?
- CLDX Moving Average Covergence Divergence (MACD) indicator is 0.95, suggesting Celldex Therapeutics is a Buy
- Celldex Therapeutics Relative Strength Index (RSI) is 68.94, which suggest Celldex Therapeutics is overbought
- The Bollinger Bands (25) for Celldex Therapeutics is (35.74 - 39.54), which suggest Celldex Therapeutics is a Buy
- The Bollinger Bands (100) for Celldex Therapeutics is (35.43 - 42.63), which suggest Celldex Therapeutics is a Buy
* Celldex Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.